An SP1-binding site polymorphism in the COLIAI gene and osteoporosis in Egyptian patients with thalassemia major

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 2, 2011, Pages 81-85

  Hamed, Hanan M ^a   Galal, Ashraf ^a   Ghamrawy, Mona E L ^b   Abd El Azeem, Khaled ^b   Hussein, Ibtessam Ramzi ^a   Abd Elgawad, Mona Fayez ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

COLIAI gene; osteoporosis; thalassemia major

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; FERRITIN; GENOMIC DNA; GUANINE; HEMOGLOBIN; HEMOGLOBIN F; THYMIDINE; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BINDING SITE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITOMETRY; BONE DENSITY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; FEMUR; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; SCHOOL CHILD;

ADOLESCENT; ALLELES; BETA-THALASSEMIA; BINDING SITES; BONE DENSITY; CHILD; COLLAGEN TYPE I; EGYPT; FEMALE; FEMUR HEAD; GENOTYPE; HUMANS; LUMBAR VERTEBRAE; MALE; MEDITERRANEAN REGION; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SP1 TRANSCRIPTION FACTOR;

EID: 79951680862     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834248fb     Document Type: Article

References (33)

1. Mahachoklert-wattana P, Chuansumrit A, Choubtum L, Sriphrapradang A, Sirisriro R. Bone mineral density in children and young adults with beta-thalassemia tra (Pubitemid 36024238)
2. Arisal O, Deviren A, Fenerci EY, Hacihanefioglu S, Ulutin T. Polymorphism analysis in the COLIA1 gene of patiens with thalassemia major and intermedia. Hematologia 2002; 32:475-482. (Pubitemid 36665356)
3. Olivieri NF. The beta-thalassemia. N Engl J Med 1999; 341:99-109.
4. Wonke B. Annotation. Bone disease in Thalassemia major. Br J Haematol 1998; 103:897-901. (Pubitemid 29012622)
5. Perrotta S, Cappellini MD, Bertoldo F. Osteoporosis in ß-thalassemia major patients: analysis of the genetic background. Br J Haematol 2000; 111:461-466.
6. Lasco A, Morabito N, Gaudio A, Crisafulli A, Meo A. Osteoporosis and beta-thalassemia major: role of the IGF-1/IGFBP-III axis. Endocrinol Invest 2002; 25:338-344. (Pubitemid 34436129)
7. Mahachoklert-wattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metabol 2003; 88:3966-3972. (Pubitemid 37034553)
8. Wonke B, Jensen C, Hanslip JJ, Prescott E, Lalloz M, Layton M. Genetic and acquired predisposing factors and treatment of osteoporosis in thalassemia major. J Pediatr Endocrinol Metab 1998; 11:795-801.
9. Chan YL, Pang LM, Chik KW, Cheng JC, Li CK. Patterns of bone diseases in transfusion-dependent homozygous thalassemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia. Pediatr Radiol 2002; 32:492-497. (Pubitemid 36067696)
10. Raiola G, Galati MC, De Sanctis V, Nicoletti Caruso M, Pintor C. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab 2003; 2:259-266. (Pubitemid 37259059)
11. Mahachoklert-Wattana P, Chuansumrit A, Sirisrio R, Choubtum L, Sriphrapradang A. Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassemia disease. Clin Endocrinol 2003; 58:273-279. (Pubitemid 36308114)
12. Ralston SH. Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 2002; 86:2460-2466. (Pubitemid 34655301)
13. Guzeloglu-Kayisli O, Cetin Z, Keser I, Ozturk Z, Tuncer T. Relationship between Sp1 polymorphism, osteoporosis in ß thalassemia major patients. Pediatr Int 2008; 50:474-476.
14. Mann V, Hobson EE, Li B. A COLIAI Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 2001; 107:899-907. (Pubitemid 32274043)
15. Zanchetta JR, Plotkin H, Alvarez Filgueira ML Bone mass in children: normative values for the 2-20-year-old population. Bone 1995; 16 (4 Suppl):393S-399S.
16. Sanbrook J, Fritsh EF, Moniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
17. Barros ER, Kasamatsu TS, Ramaloh CA, Hauache OM, Vieira JGH, Lazsretti-Castro M. Bone mineral density in young women of the city of Sao Paulo Brazil: correlation with both collagen type 1 alpha gene polymorphism and clinical aspects. J Med Biol Res 2002; 35:885-893. (Pubitemid 35390340)
18. Tantawy AA, El Kholy M, MoustafaT, Elsedfy HH. Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major. Pediatr Endocrinol 2008; 6 (1suppl):132-135.
19. Grant SF, Reid DM, Blake G. Reduced bone density osteoporosis associated with a polymorphic Sp1 binding site in the collagen type a 1 gene. Nat Genet 1996; 14:203-205. (Pubitemid 26338805)
20. Uitterlinden AG, Burger H, Hunag Q. Relation of alleles of the collagen type I alpha 1 geneto bone density andthe riskofosteoporoticfractures in post menopausal women. N Engl J Med 1998; 338:1016-1021.
21. Bernad M, Martinez ME, Escalona M. Polymorphism in the type I collagen (COLIAI) gene and risk of fractures in post menopausal women. Bone 2002; 30:223-228. (Pubitemid 34044320)
22. Falcon-Ramirez E, Casas-Avila L, Miranda A, Diez P, Castro C, Rubio J, et al. Sp1 polymorphism in collagen I alpha1 gene is associated with osteoporosisin lumbarspineofMexicanwomen. MolBiolRep 2010 [Epub ahead of print].
23. Ji GR, Yao M, Sun CY, Zhang L, Han Z. Association of collagen type I alpha1 (COLIA1) Sp1 polymorphism with osteoporotic fracture in Caucasian postmenopausal women: a meta-analysis.J Int Med Res 2009; 37:1725-1732.
24. Pollack DR, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb A. Bone mineral metabolism in adults with beta-thalassemia major and intermedia. Br J Hematol 2000; 111:902-907. (Pubitemid 32098930)
25. Shamshirsaz AA, Bekheirnia MR, KamgarM, Pourzahedgilani N, Bouzari N, Habibzadeh M. Metabolic and endocrinologic complications in betathalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003; 3:4-5.
26. Carbonell Sala S, Masi L, Marini F, Del Monte F, Falchetti A, Franceschelli F, Brandi ML Genetics and pharmacogenetics of osteoporosis. J Endocrinal Invest 2005; 28 (10 Suppl):2-7.
27. Han KO, Moon LG, Kang YS, Chung HY, Min HK. Non association of oestrogen receptor genotypes with bone mineral density and oestrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 1997; 82:991-995. (Pubitemid 27166631)
28. Berg JP, Lehmann EH, Stakkestad JA, Haug E, Halse J. The Sp1 binding site polymorphism in the collagen type 1 alpha 1 (COLIA1) gene is not associated with BMD in healthy children, adolescents, and young adults. Eur J Endocrinol 2000; 143:261-265. (Pubitemid 30622361)
29. Jin H, Evangelou E, Ioannidis JP, Ralston SH. Polymorphisms in the 5' flank of COL1A1 gene and osteoporosis: meta-analysis of published studies. Osteoporos Int 2010 [Epub ahead of print].
30. Gaudio A, Morabito N, Xourafa A, Curro M, Czccamo D, Ferlazzo N, et al. Role of genetic pattern on bone mineral density in thalassemic patients. Clin Biochem 2010; 43:805-807.
31. Keen RW, Woodford-Richens KL, Grant SFA, Ralston SH, Lanchbury JS. Polymorphism at the type I collagen (COLIAI) locus is associated with reduced bone mineral density, increased fracture risk and increased collagen turnover. Arthritis Rheum 1999; 42:285-290. (Pubitemid 29072845)
32. McGuigan FE, Armbrecht G, Smith R, Felsenberg D, Reid DM, Ralston SH. Prediction of osteoporotic fractures by bone densitometry and COLIAI genotyping: a prospective population-basad study in men and women. Osteoporos Int 2001; 12:91-96. (Pubitemid 32244660)
33. MannV, Ralston SH. Meta-analysisofCOLIAISp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 2003; 32: 711-717.